Found 8 matching trials
A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy to L-dopa in the Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations and Dyskinesia. PHASE2 This is a multicenter, randomized, double blind, pramipexole-controlled par...
Show More Location
Site Reference ID/Investigator# 45433
Learn More & Join Trial
SLV308 for Treatment of Patients With Early Parkinson's Disease PHASE3 This study is a multicenter, randomized, double blind, parallel group study...
Show More Learn More & Join Trial
An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients PHASE3 This is a multicenter, 6 months open label safety extension study for all p...
Show More Learn More & Join Trial
SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations PHASE3 This study is a multicenter, randomized, double blind, parallel group study...
Show More Learn More & Join Trial
An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD Patients PHASE3 This is a multicenter, 6 months open label safety extension study for all p...
Show More Learn More & Join Trial
SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson Disease PHASE3 This is a multicenter, randomized, double blind, parallel group study of 6 ...
Show More Learn More & Join Trial
Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's Disease PHASE3 This study is a multicenter, randomized, double-blind, placebo controlled, ...
Show More Learn More & Join Trial
An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations. PHASE3 This study is a multicenter, 9 months, open label extension study for all p...
Show More Location
S308.3.007 Site # 220
Learn More & Join Trial